Navigation Links
Amarantus BioSciences Announces MANF Demonstrates Superiority over GDNF in Neurorestoration Behavioural Animal Model of Parkinson's Disease
Date:10/25/2012

nigra, and creating Parkinson's-like behavioural symptoms that were quantified by counting the number of times the rats turned in a circle in the same direction (behavioural deficits) in a given 120 minute period of time. MANF and GDNF were delivered directly into the substantia nigra of separate groups of rats 2 weeks following the administration of the 6-OHDA, in order to mimic as closely as possible in rats the treatment setting in humans where treatment would be administered after an extended timeframe following the initiation of dopaminergic nerve terminal retraction, each at the optimal dosing level of 10 micrograms. Four weeks following MANF treatment into the substantia nigra, behavioural deficits were reduced by ~43%, and six weeks following MANF treatment, behavioural deficits were reduced by ~53%; four weeks following GDNF treatment into the substantia nigra, behavioural deficits were reduced by ~16%, and six weeks following GDNF treatment, behavioural deficits actually increased by ~20%. 

"The data obtained in this study provide clear evidence that MANF had a strong positive and restorative effect on the behaviour of animals in this pre-clinical Parkinson's disease study when delivered to the substantia nigra, whereas GDNF had no such effect," said John W. Commissiong PhD, Chief Scientist at Amarantus and former Head of the Neurotrophic Factors Group at the National Institutes of Health. "The localization of the drug treatment in this study is critical because, as Parkinson's disease progresses, dopaminergic nerve terminals typically retract from the striatum towards their cell bodies in the substantia nigra, resulting in the disruption of the basal ganglia network that is responsible for proper motor function. Translated, the longer you have Parkinson's disease, the less likely a neurotrophic factor will work when delivered to the striatum because there are fewer dopaminergic nerve terminals remaining to act on, and so neurotrophic factor d
'/>"/>

SOURCE Amarantus BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
2. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015 Concord Medical Services Holdings ... leading specialty hospital management solution provider and operator of the ... China , announced today that an Extraordinary General ... 10:00 a.m. ( Beijing time) at CCM,s ... 3rd Ring Road East, Dongcheng District, Beijing, P.R. ...
(Date:5/4/2015)... 2015  Caris Life Sciences®, a leading biotechnology ... medicine, today announced the designation of MedStar Health ... Caris Centers of Excellence for Precision Medicine Network™ ... Maryland and the Washington, ... in oncology research and treatment, with MedStar Georgetown ...
(Date:5/4/2015)... , TX and VANCOUVER , May 4, ... (TSX-V: EPI) announced today that it has received notification from ... the US that the Company,s IND application, filed March 31, ... the FDA of additional chemistry and pharmaceutical data related to ... a Certificate of Analysis on drug product. The ...
Breaking Medicine Technology:Concord Medical Services Announces 2015 Extraordinary General Meeting of Shareholders 2Caris Life Sciences Designates MedStar Health a Caris Center of Excellence 2Caris Life Sciences Designates MedStar Health a Caris Center of Excellence 3ESSA Pharma Inc. Receives FDA Response on IND Application 2ESSA Pharma Inc. Receives FDA Response on IND Application 3ESSA Pharma Inc. Receives FDA Response on IND Application 4
... , HOUSTON, Oct. 5 PAC, a leading global ... process applications, announces the introduction of the ANTEK MultiTek(TM) ... sulfur , nitrogen, and halides. Industries include ... Pharmaceutical, Environmental, and many more. , "MultiTek(TM) is ...
... , SAN DIEGO, Oct. 2 Pharmatek Laboratories, Inc., ... pharmaceutical industry, announced that it is the first CRO ... enhancing the company,s preclinical and early phase clinical GMP ... to move our customers, drug candidates into the clinic ...
Cached Medicine Technology:New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides 2Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast 2
(Date:5/4/2015)... Louis, Missouri (PRWEB) May 04, 2015 ... recognized as the “Gateway to the West,” so it ... “Gateway for Veterans Program”, says Dr. Ben Litalien, Chief ... International Franchise Association’s VetFran program and will provide veterans ... , Zerorez® is proud to have a number ...
(Date:5/3/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 03, 2015 ... . She has worked to enhance the well being of ... as a generalist in a hospital, followed by providing care for ... I worked with as an Adult Nurse Practitioner began wondering if ... coupled with the birth of my own children with my mentor ...
(Date:5/3/2015)... 03, 2015 " Bubbly Walrus ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... educational game. , The best games to play on smartphones ... of users killing brain cells with a video game that ...
(Date:5/3/2015)... 03, 2015 NuevaCare announced today that ... upcoming area seminars. The first event will take place ... Stroke Conference to be held at The Magnolia of ... May 13 during the Dementia Conference to be held ... seminars offer an excellent opportunity to learn about the ...
(Date:5/2/2015)... one of only 30 Illinois companies to be a ... Recognition Program (SHARP) certification, Essentra Specialty Tapes ... of Labor to host this special event. The ... Occupational Safety and Health Administration’s (“OSHA”) Onsite Consultation Program ... exceed all of the necessary regulations and standards, thanks ...
Breaking Medicine News(10 mins):Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3
... ... the 62nd Annual Conference of the Society for Human Resources Management (SHRM). During the ... integration to Human Resource and Payroll professionals at Booth #531 , ... Monterey Park, Calif. (Vocus) June 25, ...
... wine, grapes, blueberries, peanuts and other plants stops ... vision researchers at Washington University School of Medicine in ... vision in blinding eye diseases such as diabetic retinopathy ... in Americans over 50. The formation of new ...
... ... first patent pending method that allows for significant risk reduction for index ... the losses significantly limited or capped while reinvesting index gains accrued to ... Effect." Between 95-100% of the principal value is invested and backed by ...
... ... Values While Creating an Engaged Workforce, , ... Charlotte, NC (Vocus) June 24, 2010 -- ... “Managing the Paradox of Employee Alignment and Engagement.” The free hour-long webinar ...
... HealthDay Reporter , THURSDAY, June 24 (HealthDay News) ... the risk of invasive breast cancer by around 30 ... is considering bisphosphonate use for bone, this might be ... clinical oncologist at the Los Angeles Biomedical Research Institute ...
... trial of a novel radioactive compound readily and safely ... volunteers on brain scans and opens the doors to ... their own radioactive compounds. The results, reported by a ... Nuclear Medicine, could lead to better ways to ...
Cached Medicine News:Health News:NOVAtime participates in the Society for Human Resources Management, (SHRM) 62nd Annual Conference in San Diego, California between June 27 and June 29, 2010 2Health News:NOVAtime participates in the Society for Human Resources Management, (SHRM) 62nd Annual Conference in San Diego, California between June 27 and June 29, 2010 3Health News:Ingredient in red wine may prevent some blinding diseases 2Health News:Ingredient in red wine may prevent some blinding diseases 3Health News:Principal Protected Index Investing Provides Innovative Method to Significantly Reduce Stock Market Loss and Risk 2Health News:Principal Protected Index Investing Provides Innovative Method to Significantly Reduce Stock Market Loss and Risk 3Health News:Morehead Presents Webinar on “Managing the Paradox of Employee Alignment and Engagement”, 2Health News:Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk 2Health News:Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk 3Health News:Novel radiotracer shines new light on the brains of Alzheimer's disease patients 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: